PubMed

Arrest of hyperparathyroid bone disease with dihydrotachysterol in patients undergoing chronic hemodialysis.

Kaye M, Chatterjee G, Cohen GF.

Ann Intern Med. 1970 Aug;73(2):225-33. No abstract available. PMID: 5311514 [PubMed - indexed for MEDLINE]Related articles

Arrest of hyperparathyroid bone disease by the use of dihydrotachysterol in patients undergoing chronic hemodialysis.

Kaye M, Chatterjee G, Cohen GF, Borra S, Sagar S.

Trans Assoc Am Physicians. 1970;83:245-53. No abstract available. PMID: 5505392 [PubMed - indexed for MEDLINE]Related articles

The effects of calciferol and its metabolites on patients with chronic renal failure. I. Calciferol, dihydrotachysterol, and calcifediol.

Voigts AL, Felsenfeld AJ, Llach F.

Arch Intern Med. 1983 May;143(5):960-3. Review.PMID: 6089682 [PubMed - indexed for MEDLINE]Related articles

Evolving aspects of uremic osteodystrophy in the dialized patient.

Zucchelli P, Fusaroli M, Fabbri L, Catizone L, Pavlica P, Viglietta G, Casanova S.

J Urol Nephrol (Paris). 1976 Apr-May;82(4-5):325-8. French. No abstract available. PMID: 940176 [PubMed - indexed for MEDLINE]Related articles

Deterioration of renal bone disease in patients treated with salmon calcitonin.

Cundy T, Kanis JA, Heynen G, Paton S, Earnshaw M, Woods CG.

Clin Endocrinol (Oxf). 1982 Jan;16(1):29-37.PMID: 7042129 [PubMed - indexed for MEDLINE]Related articles

A calcium kinetic approach to the problem of renal osteodystrophy.

Gonick HC, Drinkard JP, Hertoghe J, Rubini ME.

Clin Orthop Relat Res. 1974 May;(100):315-36. No abstract available. PMID: 4838415 [PubMed - indexed for MEDLINE]Related articles

Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.

Brandi L, Daugaard H, Nielsen PK, Jensen LT, Egsmose C, Olgaard K.

Nephron. 1996;74(1):89-103. Erratum in: Nephron 1997;77(3):353. PMID: 8883025 [PubMed - indexed for MEDLINE]Related articles

Comparative biological effects of vitamins D 2 and D 3 and dihydrotachysterol 2 and dihydrotachysterol 3 in the chick.

Hibberd KA, Norman AW.

Biochem Pharmacol. 1969 Oct;18(10):2347-55. No abstract available. PMID: 4327385 [PubMed - indexed for MEDLINE]Related articles

Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.

Brossard JH, Garon J, Lepage R, Gascon-Barré M, D'Amour P.

Bone Miner. 1993 Oct;23(1):15-26.PMID: 8274876 [PubMed - indexed for MEDLINE]Related articles

[Bone loss in hemodialysis patients]

Inaba M.

Nippon Rinsho. 2007 Nov 28;65 Suppl 9:521-5. Review. Japanese. No abstract available. PMID: 18161159 [PubMed - indexed for MEDLINE]Related articles

Comparison between the results of radiocalcium studies and histological findings in a case of primary hyperparathyroidism (osteitis fibrosa cystica generalisata of von Recklinghausen) before and after removal of parathyroid adenoma.

Caniggia A, Gennari C, Guideri R, Cesari L.

J Clin Endocrinol Metab. 1966 Aug;26(8):867-74. No abstract available. PMID: 5921154 [PubMed - indexed for MEDLINE]Related articles

Treatment of bone disease in patients on chronic hemodialysis with dihydrotachysterol.

Cordy PE.

Trans Am Soc Artif Intern Organs. 1976;22:60-4.PMID: 951878 [PubMed - indexed for MEDLINE]Related articles

Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysis.

de Fremont JF, Sebert JL, Gueris J, Marie P, Coevoet B, Makdassi R, Lambrey G, Meunier P, Fournier A.

Proc Eur Dial Transplant Assoc. 1979;16:675-6. No abstract available. PMID: 232918 [PubMed - indexed for MEDLINE]Related articles

Suppression of secondary hyperparathyroidism by propranolol in renal failure patients.

Besarab A, Caro JF, Ihle BU, Burke JF Jr, Glennon JA, Fischer JA.

Nephron. 1981;27(3):127-33.PMID: 7219643 [PubMed - indexed for MEDLINE]Related articles

[Parathyroid and bone. Calcimimetics and bone metabolism]

Fukumoto S.

Clin Calcium. 2007 Dec;17(12):1865-9. Review. Japanese. PMID: 18057662 [PubMed - indexed for MEDLINE]Related articles

Treatment of bone disease with dihydrotachysterol in patients undergoing long-term hemodialysis.

Cordy PE.

Can Med Assoc J. 1977 Oct 8;117(7):766-8.PMID: 907948 [PubMed - indexed for MEDLINE]Related articlesFree article

Pathogenesis of osteomalacia in secondary hyperparathyroidism after gastrectomy.

Wortsman J, Pak CY, Bartter FC, Deftos L, Delea CS.

Am J Med. 1972 Apr;52(4):556-64. No abstract available. PMID: 5017248 [PubMed - indexed for MEDLINE]Related articles

Normocalcemic primary hyperparathyroidism with osteitis fibrosa.

Frame B, Foroozanfar F, Patton RB.

Ann Intern Med. 1970 Aug;73(2):253-7. No abstract available. PMID: 5454261 [PubMed - indexed for MEDLINE]Related articles

Plasma parathormone, calcium and phosphorus in patients with renal osteodystrophy undergoing chronic hemodialysis.

Genuth SM, Sherwood LM, Vertes V, Leonards JR.

J Clin Endocrinol Metab. 1970 Jan;30(1):138-40. No abstract available. PMID: 5409532 [PubMed - indexed for MEDLINE]Related articles

[Outcome of osseous lesions of hyperparathyroidism in a patient with chronic renal failure treated with high doses of vitamin D]

Verberckmoes R, Tanghe W, Michielsen P, Vandenbroucke J.

J Urol Nephrol (Paris). 1970 Sep;76(9):790-7. French. No abstract available. PMID: 5482082 [PubMed - indexed for MEDLINE]Related articles